drug development

How tranScrip CEO Marcin Mankowski is ‘driving forward’ drug innovation and development
How tranScrip CEO Marcin Mankowski is ‘driving forward’ drug innovation and development
Biopharma Reporter
tranScrip
drug development
innovation
Marcin Mankowski
Flag link:
How tranScrip CEO Marcin Mankowski is ‘driving forward’ drug innovation and development
How tranScrip CEO Marcin Mankowski is ‘driving forward’ drug innovation and development
Biopharma Reporter
drug development
tranScrip
innovation
Flag link:
3 Key Biotech Trends for 2023 And Beyond
3 Key Biotech Trends for 2023 And Beyond
Motley Fool
biotech
collaboration
artificial intelligence
clinical trials
drug development
Flag link:
Bayer and Bicycle Therapeutics Enter Strategic Collaboration for Development of Novel Targeted Radionuclide Therapies in Oncology
Bayer and Bicycle Therapeutics Enter Strategic Collaboration for Development of Novel Targeted Radionuclide Therapies in Oncology
BioSpace
Bayer
Bicycle Therapeutics
drug development
radiopharmaceuticals
Flag link:
Ovid partners with Waksal startup to develop drugs for rare brain disorders
Ovid partners with Waksal startup to develop drugs for rare brain disorders
BioPharma Dive
Ovid Therapeutics
Graviton Biosciences
drug development
brain disorders
Flag link:
Will Biogen’s Qalsody Be a Catalyst for Gene-Specific ALS Research?
Will Biogen’s Qalsody Be a Catalyst for Gene-Specific ALS Research?
BioSpace
Biogen
Qalsody
tofersen
ALS
drug development
R&D
Flag link:
Twist Bioscience Enters into Third Collaboration with Astellas to Support Antibody Discovery for Immunotherapies
Twist Bioscience Enters into Third Collaboration with Astellas to Support Antibody Discovery for Immunotherapies
Businesswire
Twist Bioscience
Astellas
VHH antibodies
drug discovery
drug development
Flag link:
How the IRA Will Affect Drug Development
How the IRA Will Affect Drug Development
BioSpace
Inflation Reduction Act
drug development
Flag link:
BioNTech, DualityBio to develop cancer treatment drugs in over $1.5-bln deal
BioNTech, DualityBio to develop cancer treatment drugs in over $1.5-bln deal
Reuters
cancer
BioNTech
DualityBio
drug development
Flag link:
BioNTech signs deal to co-develop OncoC4's cancer drug
BioNTech signs deal to co-develop OncoC4's cancer drug
Reuters
BioNTech
OncoC4
cancer
oncology
drug development
ONC-392
Flag link:
The state of the oncology microbiome therapeutics pipeline at a glance
The state of the oncology microbiome therapeutics pipeline at a glance
Clinical Trials Arena
oncology
cancer
microbiome
drug development
Flag link:
Flagship fledging fetches $50M to fire drugs at specific organs, fix on-target, off-tissue toxicity
Flagship fledging fetches $50M to fire drugs at specific organs, fix on-target, off-tissue toxicity
Fierce Biotech
Flagship Pioneering
drug development
Ampersand Biomedicines
Flag link:
Tempus, Pfizer partner for cancer drug development
Tempus, Pfizer partner for cancer drug development
Pharmaceutical Business Review
Pfizer
Tempus
cancer
drug development
artificial intelligence
machine learning
Flag link:
AbbVie and Capsida Biotherapeutics partner on eye disease focused gene therapies
AbbVie and Capsida Biotherapeutics partner on eye disease focused gene therapies
Biopharma Reporter
AbbVie
Capsida Biotherapeutics
eye disease
drug development
Flag link:
Bristol Myers expands footprint in India with drug development and IT center
Bristol Myers expands footprint in India with drug development and IT center
Endpoints
Bristol Myers Squibb
India
drug development
IT
Flag link:
After pandemic breather, Big Pharma sees drug development costs rise and returns sink: report
After pandemic breather, Big Pharma sees drug development costs rise and returns sink: report
Fierce Biotech
drug development
Big Pharma
Flag link:
Federal panel approves plans to safeguard lab-made virus research
Federal panel approves plans to safeguard lab-made virus research
Stat
viruses
R&D
gain of function
drug development
Flag link:
Regen BioPharma Leverages Exosome Technologies to Broaden its Survivin Cancer Immunotherapy Portfolio
Regen BioPharma Leverages Exosome Technologies to Broaden its Survivin Cancer Immunotherapy Portfolio
BioSpace
Regen Biopharma
exosomes
cancer
drug development
Flag link:
BMJ finds 96% of oncology drug developers inadequately include minority groups
BMJ finds 96% of oncology drug developers inadequately include minority groups
Clinical Trials Arena
BMJ
FDA
oncology
minorities
drug development
Flag link:
TRexBio Announces Collaboration and License Agreement with Lilly to Develop and Commercialize Novel Therapies for Immune-Mediated Diseases
TRexBio Announces Collaboration and License Agreement with Lilly to Develop and Commercialize Novel Therapies for Immune-Mediated Diseases
Businesswire
Eli Lilly
TRexBio
tregs
drug development
Flag link:

Pages